Screening Compounds

ZereneX promotes more than 300 target-focussed libraries as well as small molecule screening libraries for high-throughput screening and fragment-based research. Our focused compound libraries comprise collections of compounds with in silico predicted affinity to a target protein or predicted biological activity.

•  Disease-Based Libraries - Alzheimer's disease, diabetes, cancer

•  Phenotypic Screening Library

•  RNA Binding

•  Epigenetic Targets

•  Protein-Protein Interaction

•  Peptidomimetics

•  Glycomimetics

•  Protein Kinases

•  Proteases

•  GPCRs

•  Nuclear Receptors

•  Ion Channels

•  Fragment Libraries

•  General Activities

For further details please contact us at

Top of page

Industry News

New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS.
Read More >

More Stories


Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us